New 2025 Data Sheds Light on 340B Activity in Georgia
Pioneer Institute has released updated #340B state fact sheets for 2025
The Pioneer Institute has released updated 340B State Fact Sheets for 2025, offering a detailed look into how the 340B Drug Pricing Program is operating in each state—including Georgia. The findings raise key questions about equity, oversight, and impact on low-income communities.
In Georgia:
- 30% of the state’s 340B contract pharmacies are located outside of Georgia, including some as far away as Hawaii.
- 43% of contract pharmacies intended to serve low-income Georgians are actually located in affluent neighborhoods.
- Some hospitals, such as Northside Hospital and AU Medical Center, operate dozens of contract pharmacies—many out of state—while others serve patients effectively with far fewer.
- PBM-owned and chain pharmacies dominate the list of top 340B contract pharmacies in Georgia.
- Despite these concerns, Georgia 340B hospitals reported above-average charity care: 4.92% of operating expenses compared to the national average of 2.15%.
The data also explores:
- Which hospitals have the most (and most out-of-state) contract pharmacies
- How charity care levels vary between insured and uninsured patients
- The correlation between hospital wealth and charitable contributions
➡️ View Georgia’s full 2025 fact sheet and explore national comparisons: https://pioneerinstitute.org/340babuse/340b-state-fact-sheets
As policymakers continue to examine the effectiveness and transparency of the 340B program, this report highlights the importance of tracking how resources intended for underserved populations are actually being deployed.
GLS is proud to announce a new partnership with Apprenti This is a key step toward expanding Registered Apprenticeship programs across Georgia’s thriving life sciences sector. July 24, 2025
Georgia Life Sciences Partners with U.S. Chamber Foundation to Bring Real-World Innovation to Georgia Classrooms 60 + high school students tackle real industry challenges through national EPIC program July 7, 2025
Georgia’s Rare Disease Advisory Council (RDAC) has released its inaugural Annual Report, covering activities from April 2024 through June 2025. Established by law on May 6, 2022, and fully seated in early 2024, the Council’s mission is to ensure every Georgian living with a rare disease has timely diagnosis, coordinated care, evidence-based resources, and access to effective treatments. Key Highlights Operational Launch & Governance First official meeting in April 2024; Council now meets monthly and is guided by adopted bylaws, a mission statement, and three strategic goals. Diverse 2025 membership of clinicians, patient advocates, researchers, industry, and state-agency representatives brings cross-sector expertise to the table. Strategic Goals & Early Wins Policy Resource: Engaged state legislators and multiple agencies, delivered testimony, and supplied technical feedback on rare-disease legislation during the 2025 session. Empower the Rare Community: Drafted Georgia’s first Quality of Life Needs Assessment Survey (to launch in 2026) and attended community events such as Rare Wish and NORD’s conferences to elevate patient voices. Support the Medical Community: Provided guest lectures at Emory Medical School, the GA Bio Patient Engagement Summit, and other venues to raise clinical awareness of rare diseases. Outreach & Education Hosted nationally recognized speakers from NORD, PhRMA, and academic researchers to share best practices and policy insights with Council members. Launched a new RDAC website, improving public access to resources and Council updates. Metrics at a Glance 10 direct support requests from rare-disease patients or groups answered. 3 patient testimonials shared with policymakers. 2 community events attended and 3 listening-style presentations delivered. 2 bills supported or shaped through Council engagement. Looking Ahead to 2026 The Council will broaden its impact by hosting statewide listening sessions, finalizing and deploying the Quality of Life Survey, expanding collaborations with healthcare providers, and solidifying its role as a trusted policy resource for Georgia’s General Assembly. “United, we will help our rare community thrive for years to come.” — Beth Nguyen, RN, RDAC Chairperson Read the full 2024-2025 Annual Report HERE to see detailed accomplishments, financials, and the complete roadmap for advancing rare-disease care and research in Georgia.
